5016 Stories, most recent news story added Fri Dec 11, 2:00 am ET
Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain.
(AP:FOSTER CITY, Calif.) Gilead Sciences Inc. said Thursday an advisory committee has recommended U.S. approval of the biotechnology company's inhalable cystic fibrosis treatment candidate.
PHILADELPHIA----Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration of its Abbreviated New Drug Applications for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ Dilaudid® Tablets 2 mg, 4 mg and 8 mg.
FRESNO, Calif. — An independent watchdog agency has uncovered flaws in a crucial part of the n...
Generic drug developer Perrigo Co. said Wednesday it is being sued by Galderma and Dermalogix over plans to make a version of the plaque psoriasis treatment, Clobex spray.
FRESNO, Calif. (AP) - An independent watchdog agency warns that a crucial part of the nation's rapid-response plan is not in place if there's a pressing need to trace back food during an illness outbreak or bioterrorism attack.
FRESNO, Calif. (AP) - An independent watchdog agency warns that a crucial part of the nation's rapid-response plan is not in place if there's a pressing need to trace back food during an illness outbreak or bioterrorism attack.
Cincinnati, Ohio (December 7, 2009) —BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®.
SAN ANTONIO----Azaya Therapeutics, Inc. announced today that the Food and Drug Administration has approved its Investigational New Drug application for its lead product “ATI-1123,” a novel and improved formulation of Taxotere® , a leading chemotherapy drug with worldwide annual sales of over $2.8 billion.
When drugs approved for adults are studied in youngsters, the research yields important safety data that could guide the use of these medications in children, a report published this week indicates.
Event updates for CTIC, VION, CYTX, CLDX have been added to the FDA & Biotech Calendar.
Montgomery County's elected officials said Thursday they plan to create new tax credits and "enhance the environment for entrepreneurship" to boost the county's once-vaunted -- but now lagging -- biosciences industry.
Over 400 people participated in the study, which saw them receive either placebo or a antioxidant-rich supplement containing selenomethionnine, zinc, and vitamins A, C, and E. At the end of the study people in the antioxidant group experienced a 40 per cent reduction in the incidence of new polyps of the large bowel.
Over 400 people participated in the study, which saw them receive either placebo or a antioxidant-rich supplement containing selenomethionnine, zinc, and vitamins A, C, and E. At the end of the study people in the antioxidant group experienced a 40 per cent reduction in the incidence of new polyps of the large bowel.
Over 400 people participated in the study, which saw them receive either placebo or a antioxidant-rich supplement containing selenomethionnine, zinc, and vitamins A, C, and E. At the end of the study people in the antioxidant group experienced a 40 per cent reduction in the incidence of new polyps of the large bowel.
SILVER SPRING, Md., Dec. 10 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has notified health professionals, and advised patients, about rare but serious complications -- including deaths -- from the use of negative pressure wound therapy (NPWT).
